ARCHIVES

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

This article is from The Cancer Letter archive.

Vol. 02 No. 36 | September 3, 1976

Download PDF Visit The Full Archive

Related Articles

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

September 24, 1999

SWOG Five Drug Adjuvant Breast Study Shows Remarkable Survival For Older, Younger Women

March 30, 1979

NCI Research Plan Proposes Spending $5 Billion In FY2002.

November 3, 2000

In Brief: Calabresi: Rimer: Outstanding ”For NCAB Chair; board Should Maintain Strong Leadership Role

September 23, 1994

Herberman Outlines NSABP restructuring In Plan To NCI

May 6, 1994

It’s “High Noon” For Cancer, Vice President Says

October 2, 1998